Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Emerging Trends in Cell Biology Research 2008

By Drug Discovery Trends Editor | July 1, 2008

Drug Discovery & Development and Bioscience Technology magazines asked drug and life science researchers about current practices, trends, and research challenges in cell biology. Their answers and candid comments will be published here and in Drug Discovery & Development magazine.

View a profile of survey respondents.

View other survey questions.
Why do you study cells? 

Respondent Profile
The survey respondents work at organizations that engage in significant levels of life science research. The respondents themselves represent both management-level and staff researchers, all involved in cell biology research.

Job Titles
A third (36%) of respondents have management titles; half (52%) are scientists or professors; and, 11% are post docs/research associates.

 Cell Biology Respondents - Job Titles

 

Areas of Interest and Research
Respondent indicated a broad range of research interests, with cell signaling (62%) as the most predominant.

Emerging Trends in Cell Biology -  Respondent Research Interests 

 

 

 

 

 

 

 

 

 

Type Of Organization
Half (53%) the respondents work for public organizations (universities, hospitals, etc.).  A third (36%) work for harmaceutical/biopharmaceutical/biotechnology companies.

Emerging Trends in Cell Biology -  Respondent Organization Type 


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50